共 10 条
[1]
Systemic gene delivery expands the repertoire of effective antiangiogenic agents. Liu Y,Thor A,Shtivelman E,et al. Journal of Biological Chemistry . 1999
[2]
Biological characterizeation of subgroup of squamous cell lung carcinomas. Mattern J,Koommagi R,Volm M. et al. Clinical Cancer Research . 1999
[3]
Hepatitis B virus transactivator HBX uses a tumor promoter signallyng pathway. Kekule AS,Lauer U,Weiss L,et al. Nature . 1993
[4]
Human interleukin-6 gene is activated by Hepatitis B virus X protein in human hepatoma cells. Lee Y,Park US,Choi I,et al. Clinical Cancer Research . 1998
[5]
A link between metastasis and resistance to apoptosis of variant small cell lung carcinoma. Shtivelman E. Oncegene . 1997
[6]
Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein. Yu DY,Moon HB,Son JK,et al. Journal of Hepatology . 1999
[7]
The prognostic molecular markers in hepatocellular carcinoma. Qin LX,Tang ZY. World Journal of Gastroenterology . 2002
[8]
TIP30 has an intrinsic kinase activity required for up-regulation of a subset of apoptotic genes. Xiao H,Palhan V,Yang Y,et al. EMBO Journal . 2000
[9]
A cofactor, TIP30, specifically enhances HIV-1 Tat-activated transcription. Xiao H,Tao Y,Greenblatt J,et al. Proceedings of the National Academy of Sciences of the United States of America . 1998
[10]
Expression of mutated hepatitis B virus X genes in human hepatocellular carcinomas. Poussin K,Dienes H,Sirma H,et al. International Journal of Cancer . 1999